Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1991 5
1992 1
1993 1
1994 4
1995 4
1996 1
1997 1
1998 4
1999 2
2000 6
2001 3
2002 3
2003 8
2004 6
2005 6
2006 4
2007 11
2008 8
2009 6
2010 6
2011 5
2012 3
2013 4
2014 1
2015 4
2016 3
2019 1
2020 5
2021 1
2022 5
2023 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
Abiraterone in metastatic prostate cancer without previous chemotherapy.
Ryan CJ, Smith MR, de Bono JS, Molina A, Logothetis CJ, de Souza P, Fizazi K, Mainwaring P, Piulats JM, Ng S, Carles J, Mulders PF, Basch E, Small EJ, Saad F, Schrijvers D, Van Poppel H, Mukherjee SD, Suttmann H, Gerritsen WR, Flaig TW, George DJ, Yu EY, Efstathiou E, Pantuck A, Winquist E, Higano CS, Taplin ME, Park Y, Kheoh T, Griffin T, Scher HI, Rathkopf DE; COU-AA-302 Investigators. Ryan CJ, et al. N Engl J Med. 2013 Jan 10;368(2):138-48. doi: 10.1056/NEJMoa1209096. Epub 2012 Dec 10. N Engl J Med. 2013. PMID: 23228172 Free PMC article. Clinical Trial.
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study.
Ryan CJ, Smith MR, Fizazi K, Saad F, Mulders PF, Sternberg CN, Miller K, Logothetis CJ, Shore ND, Small EJ, Carles J, Flaig TW, Taplin ME, Higano CS, de Souza P, de Bono JS, Griffin TW, De Porre P, Yu MK, Park YC, Li J, Kheoh T, Naini V, Molina A, Rathkopf DE; COU-AA-302 Investigators. Ryan CJ, et al. Lancet Oncol. 2015 Feb;16(2):152-60. doi: 10.1016/S1470-2045(14)71205-7. Epub 2015 Jan 16. Lancet Oncol. 2015. PMID: 25601341 Clinical Trial.
Editorial comment.
Vieweg J. Vieweg J. J Urol. 2012 May;187(5):1582. doi: 10.1016/j.juro.2011.12.163. Epub 2012 Mar 14. J Urol. 2012. PMID: 22425073 No abstract available.
Immunotherapy of surgical malignancies.
Morse MA, Lyerly HK, Clay TM, Abdel-Wahab O, Chui SY, Garst J, Gollob J, Grossi PM, Kalady M, Mosca PJ, Onaitis M, Sampson JH, Seigler HF, Toloza EM, Tyler D, Vieweg J, Yang Y. Morse MA, et al. Among authors: vieweg j. Curr Probl Surg. 2004 Jan;41(1):15-132. doi: 10.1016/S0011384003001321. Curr Probl Surg. 2004. PMID: 14749625 Review. No abstract available.
Reversal of tumor-mediated immunosuppression.
Vieweg J, Su Z, Dahm P, Kusmartsev S. Vieweg J, et al. Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):727s-732s. doi: 10.1158/1078-0432.CCR-06-1924. Clin Cancer Res. 2007. PMID: 17255301 Review.
Prostate cancer: targeting complexity.
Vieweg JW. Vieweg JW. Curr Opin Urol. 2008 May;18(3):261-2. doi: 10.1097/MOU.0b013e3282f9b413. Curr Opin Urol. 2008. PMID: 18382234 No abstract available.
Combination therapy for renal cell cancer: what are possible options?
Santos N, Wenger JB, Havre P, Liu Y, Dagan R, Imanirad I, Ivey AM, Zlotecki RA, Algood CB, Gilbert SM, Allegra CJ, Okunieff P, Vieweg J, Dang NH, Luesch H, Dang LH. Santos N, et al. Among authors: vieweg j. Oncology. 2011;81(3-4):220-9. doi: 10.1159/000333470. Epub 2011 Nov 12. Oncology. 2011. PMID: 22085914 Free PMC article. Review.
Clinical practice guidelines on prostate cancer: a critical appraisal.
Gupta M, McCauley J, Farkas A, Gudeloglu A, Neuberger MM, Ho YY, Yeung L, Vieweg J, Dahm P. Gupta M, et al. Among authors: vieweg j. J Urol. 2015 Apr;193(4):1153-8. doi: 10.1016/j.juro.2014.10.105. Epub 2014 Nov 4. J Urol. 2015. PMID: 25451831 Review.
111 results